Manning Paul B Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
36
Insider Buys Sum
$112.29M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Manning Paul B

According to the SEC Form 4 filings, Manning Paul B, being in a position of

  1. director at Candel Therapeutics, Inc.,
    оver the last 12 months, has bought 550458 shares for $3M, and sold 0 shares,
    over all time since 2021-07-27, has bought 3461458 shares for $23.76M, and sold 0 shares.

Biography of Manning Paul B

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $20,505,154267
Sells
 $12,782,059133

Comparison of Insiders on Amount of Buys and Sells

2026-06-04SaleLiquidia Corporation
LQDA
director
200,000
0.2298%
$63.91$12.78M+12.36%
2026-02-23PurchaseCandel Therapeutics, Inc.
CADL
director
550,458
1.0995%
$5.45$3M+76.76%
2025-11-25PurchaseVerrica Pharmaceuticals Inc.
VRCA
4.13M
43.8143%
$4.24$17.51M+13.28%
2025-09-02SaleLiquidia Corporation
LQDA
director
328,268
0.3839%
$28.78$9.45M+31.61%
2025-08-29SaleLiquidia Corporation
LQDA
director
188,232
0.2182%
$27.62$5.2M+35.35%
2025-08-28SaleLiquidia Corporation
LQDA
director
154,337
0.1824%
$27.94$4.31M+36.42%
2025-05-30PurchaseTaysha Gene Therapies, Inc.
TSHA
10 percent owner
750,000
0.3545%
$2.75$2.06M+67.16%
2024-12-16PurchaseCandel Therapeutics, Inc.
CADL
director
1.25M
3.786%
$6.00$7.5M-7.79%
2024-11-22PurchaseVerrica Pharmaceuticals Inc.
VRCA
22.92M
45.1241%
$0.89$20.4M-40%
2024-09-12PurchaseLiquidia Corporation
LQDA
director
337,078
0.4019%
$8.90$3M+44.65%
2024-06-27PurchaseTaysha Gene Therapies, Inc.
TSHA
10 percent owner
1.33M
0.7863%
$2.25$3M-6.45%
2023-12-14PurchaseLiquidia Corporation
LQDA
director
279,330
0.4244%
$7.16$2M+67.76%
2023-11-17PurchaseTaysha Gene Therapies, Inc.
TSHA
10 percent owner
100,000
0.0519%
$1.63$163,000+27.65%
2023-08-16PurchaseTaysha Gene Therapies, Inc.
TSHA
10 percent owner
16.47M
11.9647%
$0.90$14.82M+19.17%
2023-07-24PurchaseVerrica Pharmaceuticals Inc.
VRCA
200,000
0.4567%
$5.02$1M+6.65%
2022-10-31PurchaseTaysha Gene Therapies, Inc.
TSHA
director
1.5M
3.9684%
$2.00$3M-35.47%
2022-07-05PurchaseVerrica Pharmaceuticals Inc.
VRCA
4.76M
9.9243%
$2.10$10M+61.6%
2022-04-18PurchaseLiquidia Corporation
LQDA
392,156
0.6258%
$5.10$2M+9.53%
2022-02-03PurchaseTaysha Gene Therapies, Inc.
TSHA
76,602
0.2022%
$7.84$600,560-59%
2022-02-02PurchaseTaysha Gene Therapies, Inc.
TSHA
125,000
0.3321%
$7.77$971,250-57.83%
Total: 43
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.